464 related articles for article (PubMed ID: 31874447)
1. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y
Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
3. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
Piao XM; Cha EJ; Yun SJ; Kim WJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779
[TBL] [Abstract][Full Text] [Related]
4. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.
de Nóbrega M; Dos Reis MB; Pereira ÉR; de Souza MF; de Syllos Cólus IM
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2893-2910. PubMed ID: 35922694
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis.
Cho S; Yang HC; Rhee WJ
Biosens Bioelectron; 2019 Dec; 146():111749. PubMed ID: 31600625
[TBL] [Abstract][Full Text] [Related]
6. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
8. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
9. Exosomal noncoding RNAs in prostate cancer.
Movahedpour A; Khatami SH; Karami N; Vakili O; Naeli P; Jamali Z; Shabaninejad Z; Tazik K; Behrouj H; Ghasemi H
Clin Chim Acta; 2022 Dec; 537():127-132. PubMed ID: 36330945
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
Filella X; Foj L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis.
Gao Z; Pang B; Li J; Gao N; Fan T; Li Y
Front Cell Dev Biol; 2021; 9():679527. PubMed ID: 34017837
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D
Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M
Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
15. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
Joković SM; Dobrijević Z; Kotarac N; Filipović L; Popović M; Korać A; Vuković I; Savić-Pavićević D; Brajušković G
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553586
[TBL] [Abstract][Full Text] [Related]
16. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population.
Matijašević Joković S; Korać A; Kovačević S; Djordjević A; Filipović L; Dobrijević Z; Brkušanin M; Savić-Pavićević D; Vuković I; Popović M; Brajušković G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542507
[TBL] [Abstract][Full Text] [Related]
17. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
18. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
